Evidence map›Paper›PMID 22384840›Full record

ReviewCurrent HIV research2012

Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects.

Gary A Jarvis, Theresa L Chang

Abstract readReview
In one paragraph

Review in Current HIV research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Clinical Performance of Cas13a-based Point-of-Care Lateral Flow Assay for DetectingmedRxiv : the preprint server for health sciences · 2024
    Article
  9. Article
  10. Development of Cas13a-based Assays formedRxiv : the preprint server for health sciences · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Anti-Virulence Therapeutic Approaches forAntibiotics (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gary A JarvisCenter for Immunochemistry, Veterans Affairs Medical Center, San Francisco, CA 94121, USA.
Theresa L Chang
San Francisco VA Medical Center · US

Funding

Bacterial STI and Innate Immunity in HIV SusceptibilityR01AI063927 · NIAID · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI JARVIS, GARY A · 2005 to 2009
$2.9M
Defensins in STI-Mediated Enhanced HIV InfectivityR01AI081559 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI CHANG, THERESA L · 2010 to 2014
$2.1M
NIAID NIH HHS AI063927NIAID NIH HHS AI AI081559NIAID NIH HHS R01 AI063927NIAID NIH HHS R01 AI081559
6 · The paper itself

Abstract

Neisseria gonorrhoeae (GC), a major cause of pelvic inflammatory disease, can facilitate HIV transmission. In response to GC infection, genital epithelial cells can produce cytokines, chemokines and defensins to modulate HIV infection and infectivity. GC can also induce the production of cytokines and chemokines in monocytes and modulate T cell activation. In vivo, an increase in the number of endocervical CD4+ T cells has been found in GC-infected women. Additionally, GC appears to modulate HIV-specific immune responses in HIV-exposed sex workers. Interestingly, in vitro, GC exhibits HIV enhancing or inhibitory effects depending on the HIV target cells. This review summarizes molecular and immunological aspects of the modulation of HIV infection and transmission by GC. Future studies using a multi-cellular system or in animal models will offer insight into the mechanisms by which GC increases HIV transmission.

Indexed as

CD4-Positive T-LymphocytesEpithelial CellsFemaleGonorrheaHIV-1HIV SeropositivityHumansInterleukin-1betaInterleukin-6Interleukin-8Lymphocyte ActivationMaleNeisseria gonorrhoeaeSex WorkersTumor Necrosis Factor-alphaInterleukin-1betaInterleukin-6Interleukin-8Tumor Necrosis Factor-alpha

Identifiers

PMID22384840
PMCPMC4149178
OpenAlexW1964961805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.